The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
DALLAS, Sept. 17, 2024 (GLOBE NEWSWIRE) -- The specialty care platform formerly known as Employer Direct Healthcare (EDH) has become Lantern, and the company is announcing its newest product offering ...
DETROIT--(BUSINESS WIRE)--Uptiv Health today announced the launch of a new hybrid infusion care experience, providing a holistic approach to care that includes personalized in-person care and extends ...
DALLAS--(BUSINESS WIRE)--Advanced Infusion Care, a division of AIS Healthcare, now offers LEQEMBI™, developed by Eisai Co., Ltd., for the treatment of patients with Alzheimer’s disease. The nationally ...
As employers look for new ways to make their healthcare benefits as effective and affordable as possible, two companies have partnered to bring infusion care closer to home. Processing Content ...
Come renewal season, employers tend to focus their health benefit strategies on the usual suspects: increasing costs of prescription drugs, chronic health conditions like cancer and diabetes, and the ...
Infusion therapy is a lifeline for people living with autoimmune disorders and chronic conditions. It's also frequently associated with cold hospital rooms and crushing financial stress. But two ...
GAYLORD — A collaboration between two lifelong friends and business partners has resulted in a new infusion therapy center meeting recent requirements of private insurance companies. Specialty ...
In 1993, the first effective enzyme replacement therapy (ERT) for a genetic disease, Ceredase (Genzyme Corporation, Cambridge, MA), was approved for use in patients with Gaucher disease. Over the next ...
Missed the event? Explore this session and others from leading infusion centers on the Transform Hospital Operations Virtual Summit page. Question: Your company LeanTaaS partners with a large number ...
The development of an insulin infusion protocol was initiated by key contributors from a team of nurses, dietitians, pharmacists, and physicians. The physician members were from various specialties, ...
Providers of specialty infusion medications are attracting private equity interest due to their “significant underlying tailwinds and high margins,” Anjali Jolly, managing partner of Acon Investments, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results